Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy

Autor: DE NICOLA, Luca, CHIODINI, Paolo, ZOCCALI C, BORRELLI S, CIANCIARUSO B, DI IORIO B, SANTORO D, GIANCASPRO V, ABATERUSSO C, GALLO, Ciro, CONTE, Giuseppe, MINUTOLO, Roberto, FOR THE SIN TABLE CKD STUDY GROUP, ZAMBOLI, Pasquale
Přispěvatelé: DE NICOLA, Luca, Chiodini, Paolo, Zoccali, C, Borrelli, S, Cianciaruso, B, DI IORIO, B, Santoro, D, Giancaspro, V, Abaterusso, C, Gallo, Ciro, Conte, Giuseppe, Minutolo, Roberto, FOR THE SIN TABLE CKD STUDY, Group, Zamboli, Pasquale, De Nicola, L, Chiodini, P, Cianciaruso, Bruno, Di Iorio, B, Gallo, C, Conte, G, Minutolo, R, SIN TABLE CKD Study, Group
Jazyk: angličtina
Rok vydání: 2011
Předmět:
Nephrology
Male
Time Factors
Epidemiology
Kaplan-Meier Estimate
urologic and male genital diseases
Critical Care and Intensive Care Medicine
Severity of Illness Index
Risk Factors
Ambulatory Care
Cumulative incidence
Prospective Studies
Prospective cohort study
Aged
80 and over

education.field_of_study
Incidence
Continuity of Patient Care
Middle Aged
female genital diseases and pregnancy complications
Proteinuria
Treatment Outcome
Italy
Cohort
Disease Progression
Female
Kidney Diseases
Glomerular Filtration Rate
medicine.medical_specialty
Population
CKD conservative treatment
Risk Assessment
Ambulatory care
Internal medicine
Severity of illness
medicine
Humans
Intensive care medicine
education
Aged
Proportional Hazards Models
Transplantation
Analysis of Variance
Chi-Square Distribution
business.industry
Original Articles
medicine.disease
nephrology care
Nonlinear Dynamics
Kidney Failure
Chronic

business
Kidney disease
Popis: Prognosis in nondialysis chronic kidney disease (CKD) patients under regular nephrology care is rarely investigated. Design, setting, participants,measurements We prospectively followed from 2003 to death or June 2010 a cohort of 1248 patients with CKD stages 3 to 5 and previous nephrology care ≥1 year in 25 Italian outpatient nephrology clinics. Cumulative incidence of ESRD or death before ESRD were estimated using the competing-risk approach.Estimated rates (per 100 patient-years) of ESRD and death 8.3 (95% confidence interval [CI], 7.4 to 9.2) and 5.9 (95% CI 5.2 to 6.6), respectively. Risk of ESRD and death increased progressively from stages 3 to 5. ESRD was more frequent than death in stage 4 and 5 CKD, whereas the opposite was true in stage 3 CKD. Younger age, lower body mass index, proteinuria, and high phosphate predicted ESRD, whereas older age, diabetes, previous cardiovascular disease, ESRD, proteinuria, high uric acid, and anemia predicted death (P0.05 for all). Among modifiable risk factors, proteinuria accounted for the greatest contribution to the model fit for either outcome.In patients receiving continuity of care in Italian nephrology clinics, ESRD was a more frequent outcome than death in stage 4 and 5 CKD, but the opposite was true in stage 3. Outcomes were predicted by modifiable risk factors specific to CKD. Proteinuria used in conjunction with estimated GFR refined risk stratification. These findings provide information, specific to CKD patients under regular outpatient nephrology care, for risk stratification that complement recent observations in the general population.
Databáze: OpenAIRE